Isomorphic Labs to Begin Trials for AI-Designed Drug by Year-End: Report

The company, which was spun out of Google DeepMind in 2021, aims to reduce the drug development timeline—traditionally 5 to 10 years—by up to tenfold using artificial intelligence.

Highlights

  • Company aims to cut traditional drug development timelines by up to tenfold.
  • Collaboration underway with pharmaceutical giants Eli Lilly and Novartis on six programs.
  • Project Astra, an AI assistant prototype, expected to roll out in 2025.

Follow Us

Isomorphic Labs to Begin Trials for AI-Designed Drug by Year-End: Report
Isomorphic Labs, a drug discovery startup owned by Google's parent Alphabet, will have its first AI-designed drug enter clinical trials by the end of 2025, according to founder Demis Hassabis. Speaking at the World Economic Forum, Hassabis revealed that the company is targeting major disease areas, including oncology, cardiovascular, and neurodegeneration, as reported by the Financial Times.

Also Read: Novo Nordisk and Valo Health Expand AI Partnership for Drug Discovery




Collaborations with Eli Lilly and Novartis

The company, which was spun out of Google DeepMind in 2021, aims to reduce the drug development timeline—traditionally 5 to 10 years—by up to tenfold using artificial intelligence. Isomorphic Labs is collaborating with pharmaceutical companies Eli Lilly and Novartis on six drug development programs, according to the report.

Project Astra: AI Assistant

Hassabis, who also serves as chief executive of Google DeepMind, reportedly said the company's prototype AI assistant, known as Project Astra, is expected to roll out to consumers later this year. According to the report, he described a near future, within three years, where there are "billions" of AI agents, "negotiating with each other on behalf of the vendor and the customer." This development, he said, would require a rethinking of the web itself.

However, Hassabis urged more caution and coordination among leading AI developers in developing artificial general intelligence (AGI), warning of potential misuse by malicious actors.

Threaten Human Civilisation

He reportedly cautioned that the technology could threaten human civilisation if it runs out of control or is repurposed by "bad actors...for harmful ends."

Google DeepMind's ultimate goal is to create artificial general intelligence, or "a system that is capable of exhibiting all the cognitive capabilities that humans have," according to Hassabis, who reportedly added that, despite social media "hype" about it being close, true AGI was still five to 10 years away.

Also Read: Google Pushes AI Education to Change Global Narrative: Report

"If something's possible and valuable to do, people will do it," Hassabis said, according to the report. "We're past that point now with AI, the genie can’t be put back in the bottle...so we have to try and make sure to steward that into the world in as safe a way as possible."

Reported By

Kirpa B is passionate about the latest advancements in Artificial Intelligence technologies and has a keen interest in telecom. In her free time, she enjoys gardening or diving into insightful articles on AI.

Recent Comments

Sujata :

I doubt that'll happen before 2029-30.

Reliance Jio's All Data Plans will Work with Voice Plans…

Sujata :

Exactly, BSNL can't compete, they are the test bid of so called make in india telecom equipements, which I doubt…

Reliance Jio's All Data Plans will Work with Voice Plans…

Sujata :

ARPUtel to arpuJAV, smooth transition lmao XD.

Airtel Prepaid Plans with 84 Days Validity: February 2025 Edition

Sujata :

Not sure about December, but from Jan onwards they're gonna loose heavily, and from Feb it'll be at peak bcs…

BSNL Provides Free SIM Cards to Pilgrims, Strengthens Infrastructure at…

Sujata :

This is what happens when wrong people sit a right place.

TRAI Gives Recommendations for 37 GHz, 42 GHz IMT Spectrum…

Load More
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments